Hypereosinophilic syndrome and mepolizumab.
Boulware
David R
DR
Stauffer
William M
WM
Walker
Patricia F
PF
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004804:Eosinophils / Q000187:drug effects; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000209:etiology; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications / Q000175:diagnosis*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C434107:mepolizumab